NEW YORK (GenomeWeb) – NanoString Technologies yesterday reported preliminary fourth quarter and full-year 2015 financial results, with total revenues increasing about 40 percent and 30 percent, respectively.

Seattle-based NanoString projected total Q4 revenue of $21.1 million to $22.1 million, an increase of 35 percent to 42 percent over the prior year period. It also expects full-year revenues of $61.5 million to $62.5 million, an increase of 29 percent to 31 percent over fiscal year 2014, and within the firm's guidance of $60 million to $63 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.